NCT00855868View on ClinicalTrials.gov

Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Alzheimer's Disease
Interventions
DRUG

florbetapir F 18

370 MBq (10 mCi), intravenous (IV) injection, single dose

DRUG

[11C]-PIB

555 MBq (15 mCi), IV injection, single dose \[11C\]-PIB

Trial Locations (1)

19104

Research Site, Philadelphia

Sponsors
All Listed Sponsors
collaborator

American College of Radiology Imaging Network

NETWORK

collaborator

General Electric

INDUSTRY

lead

Avid Radiopharmaceuticals

INDUSTRY